Merck buying Terns in $6.7B deal to bolster its cancer portfolio before key Keytruda patent expires
Business
•
March 25, 2026
•
0 Views
Source: https://finance.yahoo.com/rss/topstories - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
